je.st
news
Bonney to retire as CEO of Cubist, current COO to take over
2014-10-20 19:58:51| Biotech - Topix.net
Cubist CEO Mike Bonney, who oversaw the most successful U.S. launch ever of an intravenous antibiotic, Cubicin, as well as the acquisition of two firms last year, is stepping down after 11 years.
Tags: to
over
take
current
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||